Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

News > United Kingdom (GB)

Please find below news from the United Kingdom (Great Britain) as well as about organisations from this country.

Total search results: 1684 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Procarta Biosystems Ltd.. (9/17/19). "Press Release: Procarta Receives CARB-X Award of up to $9.2 million". Stevenage. 2019-09-17
UCL Technology Fund. (9/16/19). "Press Release: Echopoint Raises £2.8m to Address the ‘Grey Zone’ of Heart Disease treatment". 2019-09-16
UK Biobank. (9/11/19). "Press Release: UK Biobank Leads the Way in Genetics Research to Tackle Chronic Diseases". 2019-09-11
o2h Discovery. (9/11/19). "Press Release: Cedilla Therapeutics and o2h Discovery Are Pleased to Announce Multi FTE Expansion to Their Synthetic Chemistry Collaboration". Cambridge & Cambridge, MA. 2019-09-11
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
BioAscent Discovery Ltd.. (9/9/19). "Press Release: BioAscent Expands into US Market, Appoints Julian Abery to Spearhead Growth". Newhouse. 2019-09-09
Lightcast Discovery Ltd.. (9/9/19). "Press Release: Lightcast Discovery Raises £1.3m in Seed Financing to Expand Pilot Studies". Cambridge. 2019-09-09
Mogrify Ltd.. (9/9/19). "Press Release: Mogrify Appoints Dr. Jane Osbourn, OBE as Chair". Cambridge. 2019-09-09
Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London. 2019-09-05
Owlstone Medical Ltd.. (9/5/19). "Press Release: Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply". Cambridge. 2019-09-05
Achilles Therapeutics Ltd.. (9/3/19). "Press Release: Achilles Therapeutics Raises £100 Million in Oversubscribed Series B Financing". Stevenage. 2019-09-03
Biofidelity Ltd.. (9/3/19). "Press Release: Next-Gen Molecular Assay Play, Biofidelity Secures Seed Financing and Appoints Dr Heiner Dreismann as Senior Advisor". Cambridge. 2019-09-03
Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. 2019-08-30
BioCity Group Ltd.. (8/29/19). "Press Release: BioCity Invests in Early-stage Precision Medicine Biotech Kinomica". Cheshire. 2019-08-29
Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. 2019-08-28
Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. 2019-08-27
Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire. 2019-08-27
GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. 2019-08-23
AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". 2019-08-22
AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". 2019-08-22
GlaxoSmithKline plc. (8/22/19). "Press Release: ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered every Two Months". London. 2019-08-22
Rexgenero. (8/21/19). "Press Release: Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies". London. 2019-08-21
AstraZeneca plc. (8/21/19). "Press Release: Update on the Phase III NEPTUNE Trial of Imfinzi plus Tremelimumab in Stage IV Non-small Cell Lung Cancer". 2019-08-21
GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London. 2019-08-21
Medicines and Healthcare Products Regulatory Agency (MHRA). (8/20/19). "Press Release: Dr June Raine to Become Interim Chief Executive Officer". 2019-08-20
AstraZeneca plc. (8/20/19). "Press Release: Farxiga Met Primary Endpoint in Landmark Phase III DAPA-HF Trial for the Treatment of Patients with Heart Failure". 2019-08-20
Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. 2019-08-19
Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. 2019-08-13
University College London (UCL). (8/13/19). "Press Release: Biotech Startup Secures £6.5m for Dementia Research". 2019-08-13
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. 2019-08-12
Start Codon Ltd.. (8/9/19). "Press Release: Start Codon Partners with Clustermarket and Science Entrepreneur Club to Support Life Science and Healthcare Start-ups". Cambridge. 2019-08-09
MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. 2019-08-08
Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. 2019-08-08
Moa Technology Ltd.. (8/8/19). "Press Release: MoA Technology Secures Series A Funding. Series A Funding for MoA Technology Gives Promise of Weed-free Crops in Future". 2019-08-08
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-08-07
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. 2019-08-07
TopiVert Pharma Ltd.. (8/7/19). "Press Release: TopiVert Announces Top-Line Results from THEIA-1 Phase 2b/3 Clinical Study of TOP1630 as a Treatment for Dry Eye Disease". London. 2019-08-07
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. 2019-08-05
Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. 2019-08-05
Exscientia Ltd.. (8/5/19). "Press Release: Sanofi Exercises Option on Exscientia-designed Bispecific Small Molecule for Treatment of Immunological Conditions". 2019-08-05
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. 2019-08-01
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. 2019-08-01
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". 2019-07-31
Atlantic Healthcare plc. (7/31/19). "Press Release: Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis". Cambridge. 2019-07-31
PredictImmune Ltd.. (7/30/19). "Press Release: PredictImmune Closes Series B Funding Round, Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline". Cambridge. 2019-07-30
Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. 2019-07-29
Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. 2019-07-25
Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. 2019-07-23
Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. 2019-07-22
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. 2019-07-18
Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. 2019-07-18
Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. 2019-07-18
Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. 2019-07-16
Illumina, Inc.. (7/16/19). "Press Release: Illumina Expands Genomics Accelerator to Cambridge, UK". San Diego, CA. 2019-07-16
Healx Ltd.. (7/11/19). "Press Release: Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion". 2019-07-11
Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London. 2019-07-10
Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. 2019-07-10
Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. 2019-07-09
Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. 2019-07-08
PhoreMost Ltd.. (7/8/19). "Press Release: PhoreMost and inStem Enter Structural Biology Alliance". Cambridge. 2019-07-08
Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". 2019-07-08
GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. 2019-07-03
GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. 2019-07-03
Cancer Research UK. (7/2/19). "Press Release: Cancer Research UK Forms Collaboration with SV Health Investors to Accelerate Development of Cancer Medicines". 2019-07-02
Antibodies.com. (7/2/19). "Press Release: Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less". Cambridge. 2019-07-02
Ahren Innovation Capital LLP. (7/1/18). "Press Release: Ahren Announces Fund Close". 2019-07-01
Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. 2019-06-28
Community for Analytical Measurement Science. (6/28/19). "Press Release: Community for Analytical Measurement Science Celebrates Its Launch". London. 2019-06-28
Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. 2019-06-27
Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire. 2019-06-27
Oxford Sciences Innovation. (6/26/19). "Press Release: Theolytics Limited Comes Out of Stealth Mode with Dr Ken Powell Announced as Chair of the Board". 2019-06-26
Oxford Biomedica plc. (6/26/19). "Press Release: Oxford Biomedica and Santen Enter R&D Collaboration and Option & Licence Agreement for Development of Gene Therapy vectors for Inherited Retinal Disease". Oxford & Osaka. 2019-06-26
Cobra Biologics Ltd.. (6/25/19). "Press Release: Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration". Keele & Stirling. 2019-06-25
Kymab Ltd.. (6/24/19). "Press Release: Kymab and LifeArc Enter Strategic Partnership to Discover New Medicines Using Kymab’s IntelliSelect Technologies". Cambridge. 2019-06-24
Oxford Immunotec Global plc. (6/24/19). "Press Release: Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman". Oxford & Marlborough, MA. 2019-06-24
Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". 2019-06-21
BioCity Group Ltd.. (6/18/19). "Press Release: New Carbon Capture Technology Could Help Industry and Agricultural Sector Decarbonise". 2019-06-18
Owlstone Medical Ltd.. (6/18/19). "Press Release: Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease". Cambridge. 2019-06-18
Illumina, Inc.. (6/17/19). "Press Release: Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2019-06-17
GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. 2019-06-13
Freeline Therapeutics Ltd.. (6/13/19). "Press Release: Freeline Announces Senior Leadership Transition and Completion of Series B Financing Milestones". 2019-06-13
Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". 2019-06-12
Exscientia Ltd.. (6/11/19). "Press Release: Exscientia Expands International Collaborations with Shanghai-headquartered GT Apeiron Therapeutics". Oxford. 2019-06-11
ReViral Ltd.. (6/11/19). "Press Release: ReViral Appoints Alex C. Sapir as Chief Executive Officer". London. 2019-06-11
Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. 2019-06-10
BioCity Group Ltd.. (6/7/19). "Press Release: New Contract Research Organisation for Platelet Testing". 2019-06-07
Owlstone Medical Ltd.. (6/5/19). "Press Release: Owlstone Medical and the International Association of Heat and Frost Insulators and Allied Workers Partner to Identify Breath Biomarkers for the Early Detection of Malignant Mesothelioma". Cambridge & Lanh 2019-06-05
University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". 2019-05-31
Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. 2019-05-30
Oxford Biomedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. 2019-05-28
Sciad Communications. (5/24/19). "Press Release: Sold Out Inaugural Bio Integrates Conference a Resounding Success". London. 2019-05-24
Satellite Applications Catapult. (5/23/19). "Press Release: Innovative Partnership to Embed the Power of Satellite Technology in Digitally Enabled Care". 2019-05-23
Bicycle Therapeutics plc. (5/22/19). "Press Release: Bicycle Therapeutics Announces Pricing of Initial Public Offering". Cambridge & Boston, MA. 2019-05-22
King’s College London. (5/20/19). "Press Release: Quell Therapeutics Ltd Founded for Emerging Area of Cell Therapy". 2019-05-20
Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. 2019-05-20
Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with New Investor, Seroba Life Sciences". Cambridge. 2019-05-20
LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment". 2019-05-20
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px

» top